Neurogene Inc. (NGNE)
NASDAQ·Healthcare·Biotechnology
$33.10
-0.36%
Mkt Cap $551.50M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (13 analysts)
$69.00
Range $69.00 – $69.00
Implied Upside
+108.5%
Consensus $69.00 vs current $33.10
NASDAQ·Healthcare·Biotechnology
$33.10
-0.36%
Mkt Cap $551.50M
Buy
2
Hold
0
Sell
0
Price Target (13 analysts)
$69.00
Range $69.00 – $69.00
+108.5%
Consensus $69.00 vs current $33.10